Data as of Mar 11
| 0.00 / 0.00%|
The 9 analysts offering 12-month price forecasts for Galena Biopharma Inc have a median target of 7.00, with a high estimate of 12.00 and a low estimate of 3.50. The median estimate represents a +108.96% increase from the last price of 3.35.
The current consensus among 9 polled investment analysts is to Buy stock in Galena Biopharma Inc. This rating has held steady since February, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.